Loading…

DNMT1/miR-200a/GOLM1 signaling pathway regulates lung adenocarcinoma cells proliferation

Lung adenocarcinoma (LAD) comprises about 80% of all diagnosed lung cancers. However, the underlying regulatory mechanism of LAD cell proliferation is largely unclear. The emergence of microRNAs and molecular-targeted therapies adds a new dimension in our efforts to combat this deadly disease. In th...

Full description

Saved in:
Bibliographic Details
Published in:Biomedicine & pharmacotherapy 2018-03, Vol.99, p.839-847
Main Authors: Yang, Longqiu, Luo, Pengcheng, Song, Qiong, Fei, Xuejie
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c362t-5390093e93f9365b5e1726fec990c76aca32e8cc3e4345cec75dd80ed1c259183
cites cdi_FETCH-LOGICAL-c362t-5390093e93f9365b5e1726fec990c76aca32e8cc3e4345cec75dd80ed1c259183
container_end_page 847
container_issue
container_start_page 839
container_title Biomedicine & pharmacotherapy
container_volume 99
creator Yang, Longqiu
Luo, Pengcheng
Song, Qiong
Fei, Xuejie
description Lung adenocarcinoma (LAD) comprises about 80% of all diagnosed lung cancers. However, the underlying regulatory mechanism of LAD cell proliferation is largely unclear. The emergence of microRNAs and molecular-targeted therapies adds a new dimension in our efforts to combat this deadly disease. In this work, the A549 and H1650 human lung cancer cell lines were used in this study. The proliferation was evaluated by the MTT and BrdU assay. The expression level of related proteins was detected by western blot. We reported GOLM1 was highly expressed in LAD cells and associated with low survival ratio and higher grade malignancy. Knockdown of GOLM1 repressed the LAD cell proliferation. Overexpression of GOLM1 promoted the cell proliferation. Further we found that the level of microRNA-200a (miR-200a) expression was low in LAD cells. miR-200a repress GOLM1 expression by directly targeting its 3′ UTR. Overexpression of miR-200a repressed the cell proliferation and blocked the increase of LAD cell proliferation caused by GOLM1 overexpression. Further, we found that miR-200 was downregulated by DNMT1.Overexpression of DNMT1 blocked the function of miR-200a on repressing proliferation. We then found that knockdown of DNMT1 repressed LAD cell proliferation, which could be rescued by GOLM1 overexpression. This work revealed the critical function of GOLM1/miR-200a/DNMT1 signaling pathway on regulating LAD cell proliferation, and might lay the foundation for further clinical treatment of LAD.
doi_str_mv 10.1016/j.biopha.2018.01.161
format article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_2033386689</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0753332217360304</els_id><sourcerecordid>2033386689</sourcerecordid><originalsourceid>FETCH-LOGICAL-c362t-5390093e93f9365b5e1726fec990c76aca32e8cc3e4345cec75dd80ed1c259183</originalsourceid><addsrcrecordid>eNp9kE1rGzEQhkVJqR23_6CEPeay65HG0q4ugeC0TsFuoKTQm5C1s47MfjjSbor_fdY46bGngeGZeWcexr5yyDhwNd9nW98dnmwmgBcZ8Iwr_oFNuZaQKoD8gk0hl5giCjFhlzHuAUAqLD6xidA5h0WBU_bn7ufmkc8b_ysVAHa-elhveBL9rrW1b3fJwfZPf-0xCbQbattTTOphbNuS2s7Z4HzbNTZxVNcxOYSu9hUF2_uu_cw-VraO9OWtztjv798el_fp-mH1Y3m7Th0q0acSNYBG0lhpVHIriedCVeS0Bpcr6ywKKpxDWuBCOnK5LMsCqOROSM0LnLHr894x_Xmg2JvGx9M9tqVuiEYAIhZKFXpEF2fUhS7GQJU5BN_YcDQczMmp2ZuzU3NyaoCb0ek4dvWWMGwbKv8NvUscgZszQOOfL56Cic5T66j0gVxvys7_P-EVB0mIyw</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2033386689</pqid></control><display><type>article</type><title>DNMT1/miR-200a/GOLM1 signaling pathway regulates lung adenocarcinoma cells proliferation</title><source>ScienceDirect Journals</source><creator>Yang, Longqiu ; Luo, Pengcheng ; Song, Qiong ; Fei, Xuejie</creator><creatorcontrib>Yang, Longqiu ; Luo, Pengcheng ; Song, Qiong ; Fei, Xuejie</creatorcontrib><description>Lung adenocarcinoma (LAD) comprises about 80% of all diagnosed lung cancers. However, the underlying regulatory mechanism of LAD cell proliferation is largely unclear. The emergence of microRNAs and molecular-targeted therapies adds a new dimension in our efforts to combat this deadly disease. In this work, the A549 and H1650 human lung cancer cell lines were used in this study. The proliferation was evaluated by the MTT and BrdU assay. The expression level of related proteins was detected by western blot. We reported GOLM1 was highly expressed in LAD cells and associated with low survival ratio and higher grade malignancy. Knockdown of GOLM1 repressed the LAD cell proliferation. Overexpression of GOLM1 promoted the cell proliferation. Further we found that the level of microRNA-200a (miR-200a) expression was low in LAD cells. miR-200a repress GOLM1 expression by directly targeting its 3′ UTR. Overexpression of miR-200a repressed the cell proliferation and blocked the increase of LAD cell proliferation caused by GOLM1 overexpression. Further, we found that miR-200 was downregulated by DNMT1.Overexpression of DNMT1 blocked the function of miR-200a on repressing proliferation. We then found that knockdown of DNMT1 repressed LAD cell proliferation, which could be rescued by GOLM1 overexpression. This work revealed the critical function of GOLM1/miR-200a/DNMT1 signaling pathway on regulating LAD cell proliferation, and might lay the foundation for further clinical treatment of LAD.</description><identifier>ISSN: 0753-3322</identifier><identifier>EISSN: 1950-6007</identifier><identifier>DOI: 10.1016/j.biopha.2018.01.161</identifier><identifier>PMID: 29710483</identifier><language>eng</language><publisher>France: Elsevier Masson SAS</publisher><subject>A549 Cells ; Adenocarcinoma - genetics ; Adenocarcinoma - pathology ; Adenocarcinoma of Lung ; Cell Line, Tumor ; Cell proliferation ; Cell Proliferation - genetics ; DNA (Cytosine-5-)-Methyltransferase 1 - genetics ; DNMT ; Down-Regulation ; Gene Expression Regulation, Neoplastic ; Gene Knockdown Techniques ; GOLM1 ; Humans ; Lung adenocarcinoma ; Lung Neoplasms - genetics ; Lung Neoplasms - pathology ; Membrane Proteins - genetics ; MicroRNAs - genetics ; miR-200a ; Signal Transduction - genetics</subject><ispartof>Biomedicine &amp; pharmacotherapy, 2018-03, Vol.99, p.839-847</ispartof><rights>2018 Elsevier Masson SAS</rights><rights>Copyright © 2018 Elsevier Masson SAS. All rights reserved.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c362t-5390093e93f9365b5e1726fec990c76aca32e8cc3e4345cec75dd80ed1c259183</citedby><cites>FETCH-LOGICAL-c362t-5390093e93f9365b5e1726fec990c76aca32e8cc3e4345cec75dd80ed1c259183</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/29710483$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Yang, Longqiu</creatorcontrib><creatorcontrib>Luo, Pengcheng</creatorcontrib><creatorcontrib>Song, Qiong</creatorcontrib><creatorcontrib>Fei, Xuejie</creatorcontrib><title>DNMT1/miR-200a/GOLM1 signaling pathway regulates lung adenocarcinoma cells proliferation</title><title>Biomedicine &amp; pharmacotherapy</title><addtitle>Biomed Pharmacother</addtitle><description>Lung adenocarcinoma (LAD) comprises about 80% of all diagnosed lung cancers. However, the underlying regulatory mechanism of LAD cell proliferation is largely unclear. The emergence of microRNAs and molecular-targeted therapies adds a new dimension in our efforts to combat this deadly disease. In this work, the A549 and H1650 human lung cancer cell lines were used in this study. The proliferation was evaluated by the MTT and BrdU assay. The expression level of related proteins was detected by western blot. We reported GOLM1 was highly expressed in LAD cells and associated with low survival ratio and higher grade malignancy. Knockdown of GOLM1 repressed the LAD cell proliferation. Overexpression of GOLM1 promoted the cell proliferation. Further we found that the level of microRNA-200a (miR-200a) expression was low in LAD cells. miR-200a repress GOLM1 expression by directly targeting its 3′ UTR. Overexpression of miR-200a repressed the cell proliferation and blocked the increase of LAD cell proliferation caused by GOLM1 overexpression. Further, we found that miR-200 was downregulated by DNMT1.Overexpression of DNMT1 blocked the function of miR-200a on repressing proliferation. We then found that knockdown of DNMT1 repressed LAD cell proliferation, which could be rescued by GOLM1 overexpression. This work revealed the critical function of GOLM1/miR-200a/DNMT1 signaling pathway on regulating LAD cell proliferation, and might lay the foundation for further clinical treatment of LAD.</description><subject>A549 Cells</subject><subject>Adenocarcinoma - genetics</subject><subject>Adenocarcinoma - pathology</subject><subject>Adenocarcinoma of Lung</subject><subject>Cell Line, Tumor</subject><subject>Cell proliferation</subject><subject>Cell Proliferation - genetics</subject><subject>DNA (Cytosine-5-)-Methyltransferase 1 - genetics</subject><subject>DNMT</subject><subject>Down-Regulation</subject><subject>Gene Expression Regulation, Neoplastic</subject><subject>Gene Knockdown Techniques</subject><subject>GOLM1</subject><subject>Humans</subject><subject>Lung adenocarcinoma</subject><subject>Lung Neoplasms - genetics</subject><subject>Lung Neoplasms - pathology</subject><subject>Membrane Proteins - genetics</subject><subject>MicroRNAs - genetics</subject><subject>miR-200a</subject><subject>Signal Transduction - genetics</subject><issn>0753-3322</issn><issn>1950-6007</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2018</creationdate><recordtype>article</recordtype><recordid>eNp9kE1rGzEQhkVJqR23_6CEPeay65HG0q4ugeC0TsFuoKTQm5C1s47MfjjSbor_fdY46bGngeGZeWcexr5yyDhwNd9nW98dnmwmgBcZ8Iwr_oFNuZaQKoD8gk0hl5giCjFhlzHuAUAqLD6xidA5h0WBU_bn7ufmkc8b_ysVAHa-elhveBL9rrW1b3fJwfZPf-0xCbQbattTTOphbNuS2s7Z4HzbNTZxVNcxOYSu9hUF2_uu_cw-VraO9OWtztjv798el_fp-mH1Y3m7Th0q0acSNYBG0lhpVHIriedCVeS0Bpcr6ywKKpxDWuBCOnK5LMsCqOROSM0LnLHr894x_Xmg2JvGx9M9tqVuiEYAIhZKFXpEF2fUhS7GQJU5BN_YcDQczMmp2ZuzU3NyaoCb0ek4dvWWMGwbKv8NvUscgZszQOOfL56Cic5T66j0gVxvys7_P-EVB0mIyw</recordid><startdate>201803</startdate><enddate>201803</enddate><creator>Yang, Longqiu</creator><creator>Luo, Pengcheng</creator><creator>Song, Qiong</creator><creator>Fei, Xuejie</creator><general>Elsevier Masson SAS</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>201803</creationdate><title>DNMT1/miR-200a/GOLM1 signaling pathway regulates lung adenocarcinoma cells proliferation</title><author>Yang, Longqiu ; Luo, Pengcheng ; Song, Qiong ; Fei, Xuejie</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c362t-5390093e93f9365b5e1726fec990c76aca32e8cc3e4345cec75dd80ed1c259183</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2018</creationdate><topic>A549 Cells</topic><topic>Adenocarcinoma - genetics</topic><topic>Adenocarcinoma - pathology</topic><topic>Adenocarcinoma of Lung</topic><topic>Cell Line, Tumor</topic><topic>Cell proliferation</topic><topic>Cell Proliferation - genetics</topic><topic>DNA (Cytosine-5-)-Methyltransferase 1 - genetics</topic><topic>DNMT</topic><topic>Down-Regulation</topic><topic>Gene Expression Regulation, Neoplastic</topic><topic>Gene Knockdown Techniques</topic><topic>GOLM1</topic><topic>Humans</topic><topic>Lung adenocarcinoma</topic><topic>Lung Neoplasms - genetics</topic><topic>Lung Neoplasms - pathology</topic><topic>Membrane Proteins - genetics</topic><topic>MicroRNAs - genetics</topic><topic>miR-200a</topic><topic>Signal Transduction - genetics</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Yang, Longqiu</creatorcontrib><creatorcontrib>Luo, Pengcheng</creatorcontrib><creatorcontrib>Song, Qiong</creatorcontrib><creatorcontrib>Fei, Xuejie</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Biomedicine &amp; pharmacotherapy</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Yang, Longqiu</au><au>Luo, Pengcheng</au><au>Song, Qiong</au><au>Fei, Xuejie</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>DNMT1/miR-200a/GOLM1 signaling pathway regulates lung adenocarcinoma cells proliferation</atitle><jtitle>Biomedicine &amp; pharmacotherapy</jtitle><addtitle>Biomed Pharmacother</addtitle><date>2018-03</date><risdate>2018</risdate><volume>99</volume><spage>839</spage><epage>847</epage><pages>839-847</pages><issn>0753-3322</issn><eissn>1950-6007</eissn><abstract>Lung adenocarcinoma (LAD) comprises about 80% of all diagnosed lung cancers. However, the underlying regulatory mechanism of LAD cell proliferation is largely unclear. The emergence of microRNAs and molecular-targeted therapies adds a new dimension in our efforts to combat this deadly disease. In this work, the A549 and H1650 human lung cancer cell lines were used in this study. The proliferation was evaluated by the MTT and BrdU assay. The expression level of related proteins was detected by western blot. We reported GOLM1 was highly expressed in LAD cells and associated with low survival ratio and higher grade malignancy. Knockdown of GOLM1 repressed the LAD cell proliferation. Overexpression of GOLM1 promoted the cell proliferation. Further we found that the level of microRNA-200a (miR-200a) expression was low in LAD cells. miR-200a repress GOLM1 expression by directly targeting its 3′ UTR. Overexpression of miR-200a repressed the cell proliferation and blocked the increase of LAD cell proliferation caused by GOLM1 overexpression. Further, we found that miR-200 was downregulated by DNMT1.Overexpression of DNMT1 blocked the function of miR-200a on repressing proliferation. We then found that knockdown of DNMT1 repressed LAD cell proliferation, which could be rescued by GOLM1 overexpression. This work revealed the critical function of GOLM1/miR-200a/DNMT1 signaling pathway on regulating LAD cell proliferation, and might lay the foundation for further clinical treatment of LAD.</abstract><cop>France</cop><pub>Elsevier Masson SAS</pub><pmid>29710483</pmid><doi>10.1016/j.biopha.2018.01.161</doi><tpages>9</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0753-3322
ispartof Biomedicine & pharmacotherapy, 2018-03, Vol.99, p.839-847
issn 0753-3322
1950-6007
language eng
recordid cdi_proquest_miscellaneous_2033386689
source ScienceDirect Journals
subjects A549 Cells
Adenocarcinoma - genetics
Adenocarcinoma - pathology
Adenocarcinoma of Lung
Cell Line, Tumor
Cell proliferation
Cell Proliferation - genetics
DNA (Cytosine-5-)-Methyltransferase 1 - genetics
DNMT
Down-Regulation
Gene Expression Regulation, Neoplastic
Gene Knockdown Techniques
GOLM1
Humans
Lung adenocarcinoma
Lung Neoplasms - genetics
Lung Neoplasms - pathology
Membrane Proteins - genetics
MicroRNAs - genetics
miR-200a
Signal Transduction - genetics
title DNMT1/miR-200a/GOLM1 signaling pathway regulates lung adenocarcinoma cells proliferation
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-29T10%3A06%3A44IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=DNMT1/miR-200a/GOLM1%20signaling%20pathway%20regulates%20lung%20adenocarcinoma%20cells%20proliferation&rft.jtitle=Biomedicine%20&%20pharmacotherapy&rft.au=Yang,%20Longqiu&rft.date=2018-03&rft.volume=99&rft.spage=839&rft.epage=847&rft.pages=839-847&rft.issn=0753-3322&rft.eissn=1950-6007&rft_id=info:doi/10.1016/j.biopha.2018.01.161&rft_dat=%3Cproquest_cross%3E2033386689%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c362t-5390093e93f9365b5e1726fec990c76aca32e8cc3e4345cec75dd80ed1c259183%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=2033386689&rft_id=info:pmid/29710483&rfr_iscdi=true